bids

Genzyme Rejects Sanofi-Aventis Takeover Bid

Genzyme, which makes drugs to treat leukemia and multiple sclerosis, has rejected a hostile takeover bid from French drugmaker Sanofi-Aventis. The offer "dramatically undervalues" Genzyme, the company said Friday, putting its value about 30% higher.

HP Shares Rise On News of Kickbacks Settlement Agreement

Hewlett-Packard shares rose in after-hours trading after the company agreed to settle a lawsuit from the Justice Department, which claimed the company paid kickbacks to get recommendations for government work. The settlement will cost 2 cents per share.

Win a gift card for a penny, if you can sit in front of your computer for hours